Skip to main content

Table 1 Anthropometric variables and DXA T-score. Homogeneity in anthropometric and BMD and DXA T-score in patients with established osteoporosis compared between Alendronate group and placebo control group (Data: mean ± SD)

From: Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis

Parameters

Alendronate group

Control group

p value

Number of subjects

22

25

/

Age (years)

60.7 ± 6.4

59.1 ± 6.3

0.387

Years since menopause (YSM) (years)

11.2 ± 7.5

9.1 ± 5.7

0.290

Height (m)

154.3 ± 5.9

153.9 ± 5.3

0.825

Weight (kg)

54.3 ± 9.5

56.8 ± 8.5

0.358

Body mass index (BMI)

22.7 ± 3.0

23.9 ± 2.5

0.173

Spine T-score

-2.21 ± 0.78

-2.20 ± 0.81

0.970

Hip T-score

-1.53 ± 1.03

-1.70 ± 0.51

0.508